Marco Massari to Immunologic Factors
This is a "connection" page, showing publications Marco Massari has written about Immunologic Factors.
Connection Strength
0.017
-
TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 11; 98:106165.
Score: 0.017